Emergency Medicine Doctors in Flower Mound, TX Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Jacob John Novak, MD Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 2628 Long Prairie Rd, Suite 107, Flower Mound, TX 75022 Phone: 972-899-6666    Fax: 972-899-6665

Dr. Roberto Antonio Lopez-freeman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4400 Long Prairie Rd, Emergency Department, Flower Mound, TX 75028 Phone: 469-322-7100

Nazanin Williams, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 4400 Long Prairie Road, Flower Mound, TX 75028 Phone: 512-452-8533

John Michael Therwhanger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2913 Carterton Ct, Flower Mound, TX 75022 Phone: 214-564-1525

Dr. Long Van Nguyen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4400 Long Prairie Rd, Flower Mound, TX 75028 Phone: 469-322-7100

Shrirang Shridhar Neurgaonkar, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3611 Morriss Rd, Flower Mound, TX 75028 Phone: 972-874-3776    Fax: 972-691-1444

James Michael Muzzarelli, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2628 Long Prairie Rd, Flower Mound, TX 75022 Phone: 972-899-6660

Mark Lane Madenwald, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5304 Prince Ln, Flower Mound, TX 75022 Phone: 214-734-4868

News Archive

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

New, low-cost biosimilar for IBD therapy shows efficacy and safety

Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost.

ACS' compendium aims to strengthen security, resilience of U.S. citizens after mass casualty events

A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.

Appropriators focus quietly on omnibus spending bill

Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.

President Obama, Sec. of State discuss U.S. commitment to development, fighting disease in Africa with young African leaders

During a gathering of over 100 young African business and civil leaders at the White House on Tuesday, President Barack Obama "urged [them] to help spur economic development and fight corruption, disease and extremism on the continent," MSNBC's "First Read" blog reports.

Read more Medical News

› Verified 9 days ago